<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Methicillin-resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (MRSA) in children: Prevention and control
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Methicillin-resistant
       <i>
        Staphylococcus aureus
       </i>
       (MRSA) in children: Prevention and control
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Methicillin-resistant
        <i>
         Staphylococcus aureus
        </i>
        (MRSA) in children: Prevention and control
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Judith R Campbell, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Diane Blake, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 12, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevention and control of methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) infections in children will be discussed here. The epidemiology, clinical spectrum, and treatment of MRSA in children are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6065.html" rel="external">
          "Methicillin-resistant
          <i>
           Staphylococcus aureus
          </i>
          infections in children: Epidemiology and clinical spectrum"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6027.html" rel="external">
          "Skin and soft tissue infections in children &gt;28 days: Evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/106447.html" rel="external">
          "Skin and soft tissue infections in neonates: Evaluation and management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6057.html" rel="external">
          "
          <i>
           Staphylococcus aureus
          </i>
          in children: Overview of treatment of invasive infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H682480895">
         <span class="h1">
          ANTIMICROBIAL STEWARDSHIP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Optimal use of antimicrobial agents (ie, choice of drug, dose, route, and duration) may help to reduce the prevalence of resistant
         <em>
          S. aureus
         </em>
         , including MRSA, and may reduce the risk of MRSA colonization [
         <a href="#rid1">
          1-3
         </a>
         ]. Optimal use may also be enhanced by referring children with penicillin allergy to an allergist for skin testing (if it has not already been performed) to reduce exposure to broad-spectrum antibiotics and the risk of developing MRSA infection [
         <a href="#rid1">
          1,4
         </a>
         ]. In a meta-analysis of 18 observational studies, penicillin skin testing was negative in approximately 95 percent of inpatients with a history of penicillin allergy [
         <a href="#rid5">
          5
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/111361.html" rel="external">
          "Choice of antibiotics in penicillin-allergic hospitalized patients", section on 'Impact of penicillin allergy on care'
         </a>
         .)
        </p>
        <p>
         Additional aspects of antimicrobial stewardship in health care and outpatient settings is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13943.html" rel="external">
          "Antimicrobial stewardship in hospital settings"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/112487.html" rel="external">
          "Antimicrobial stewardship in outpatient settings"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          PREVENTION IN THE COMMUNITY
         </span>
        </p>
        <p class="headingAnchor" id="H157807388">
         <span class="h2">
          Education to reduce transmission
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRSA transmission requires contact with a colonized individual or a contaminated surface. Community-onset infections frequently recur in individuals and commonly spread within families and among children in daycare centers [
         <a href="#rid6">
          6-8
         </a>
         ]. Colonization of household dogs and cats has been described [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5529.html" rel="external">
          "Zoonoses: Dogs", section on 'Methicillin-resistant Staphylococcus aureus'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5518.html" rel="external">
          "Zoonoses: Cats", section on 'Methicillin-resistant Staphylococcus aureus'
         </a>
         .)
        </p>
        <p>
         Education of patients and family members about hygiene and cleaning of surfaces and other items that are frequently touched with bare skin (eg, door knobs, bath tubs, counters, television remote controls) is a key component of prevention of MRSA in the community.
        </p>
        <p>
         Schools and athletic teams also should be educated about hygiene and appropriate cleaning of surfaces and other items that are frequently touched with bare skin (eg, athletic equipment including wrestling, judo, and gymnastic mats).
        </p>
        <p>
         These common sense measures are not well-studied but have been effective as part of a multifaceted strategy for control of community outbreaks [
         <a href="#rid9">
          9-11
         </a>
         ]. What constitutes an "outbreak" of MRSA in the community is poorly defined in the literature. A reasonable definition is a cluster of at least three cases of MRSA in a specific population (eg, a sports team) over the course of one month.
        </p>
        <p>
         Measures for all individuals include [
         <a href="#rid12">
          12-15
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Regularly washing hands with soap and water or an alcohol-based hand gel, particularly after contact with household dogs and cats
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Maintaining good general hygiene with regular bathing, particularly after activities with skin-to-skin contact; keeping fingernails cut short and clean
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Using an appropriate over-the-counter detergent or disinfectant that specifies
         <em>
          S. aureus
         </em>
         on the product label to clean equipment and environmental surfaces that multiple people touch with bare skin
        </p>
        <p>
        </p>
        <p>
         Specific counseling for patients or caregivers of patients with MRSA skin and soft tissue infections (SSTIs) includes [
         <a href="#rid12">
          12-16
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Keeping draining wounds covered with clean, dry bandages; if the wound cannot be kept covered, avoiding participation in activities with skin-to-skin contact with other people (eg, athletic activities) until the wound is healed
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Washing hands with soap and water or an alcohol-based hand gel immediately after touching infected skin or items that directly touch a draining wound
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Avoiding reusing or sharing items that have directly contacted a draining wound (eg, common tubs, towels, clothing, bedding, bar soap, razors, athletic equipment)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Washing bed linens at least weekly and towels and washcloths after each use
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Washing and thoroughly drying clothing that has come in contact with wound drainage after each use
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the warmest temperature of water recommended on the item's label should be used for laundering, it is not necessary to use hot water or bleach [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3036757186">
         <span class="h2">
          School or child care attendance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Children with MRSA infection may attend school or child care provided that draining or open wounds or abrasions can be kept covered with a clean, dry dressing [
         <a href="#rid15">
          15,18
         </a>
         ]. Those who are colonized with MRSA should not routinely be excluded from school or child care.
        </p>
        <p class="headingAnchor" id="H1046018844">
         <span class="h2">
          Special populations
         </span>
        </p>
        <p class="headingAnchor" id="H3301243999">
         <span class="h3">
          Children with recurrent MRSA infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest intranasal and topical decolonization for children with recurrent MRSA infection despite routine hygiene measures. Other experts may have different indications for decolonization or suggest different regimens. After topical decolonization with bleach baths or
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         baths or showers, moisturizer should be generously applied; bleach and chlorhexidine both cause drying of the skin. Chlorhexidine may cause local irritation and repeated exposure may be associated with decreased susceptibility [
         <a href="#rid19">
          19,20
         </a>
         ]. (See
         <a class="local">
          'Decolonization regimens'
         </a>
         below.)
        </p>
        <p>
         We use different regimens depending on the clinical scenario:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          First or second recurrence
         </strong>
         – For children with one or two recurrences of MRSA infection, we suggest intranasal and topical decolonization for the child. We use the following regimen (
         <a class="graphic graphic_table graphicRef121267" href="/z/d/graphic/121267.html" rel="external">
          table 1
         </a>
         ) (see
         <a class="local">
          'Decolonization regimens'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment to the nares two to three times per day for one week
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         baths or showers once daily for 5 to 14 days
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multiple recurrences of MRSA despite routine hygiene measures
         </strong>
         – For children with recurrent MRSA infection despite routine hygiene measures, we suggest intranasal and topical decolonization for the child. We use the following regimen (see
         <a class="local">
          'Decolonization regimens'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment to the nares two to three times per day for one week each month for three months
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dilute bleach baths twice per week for three months
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         baths or showers once daily on the days of the week that bleach baths are not given for three months
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recurrent MRSA infection in child and MRSA infection ≥1 other household member
         </strong>
         – For children with recurrent MRSA infection despite routine hygiene measures who have ≥1 other household member with MRSA infections, we suggest intranasal and topical decolonization for all household members with
         <em>
          S. aureus
         </em>
         infections in the previous year in addition to intranasal and topical decolonization for the child [
         <a href="#rid21">
          21
         </a>
         ]. We use the regimen described above for the child and the following regimen for household members (see
         <a class="local">
          'Decolonization regimens'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment to the nares two to three times per day for one week
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dilute bleach baths twice per week for one week
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         baths or showers once daily on the days of the week that bleach baths are not given for one week
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Contacts with symptomatic infection should be treated before decolonization. It is not necessary to perform screening cultures in contacts if at least one of the previous infections was confirmed to be MRSA.
        </p>
        <p>
        </p>
        <p>
         Approximately 20 percent of patients treated for MRSA SSTI remain colonized after treatment [
         <a href="#rid22">
          22
         </a>
         ]. Decolonization of the patient and close contacts may reduce the risk of subsequent MRSA infection in the patient and their contacts.
        </p>
        <p>
         Evidence to support decolonization of the index patient to prevent recurrent MRSA infection is limited and suggests only short-term benefit [
         <a href="#rid23">
          23
         </a>
         ]. In an open-label trial in 300 patients (adults and children) with community-onset SSTI and
         <em>
          S. aureus
         </em>
         colonization, one-month eradication rates were greater following a five-day regimen of decolonization with
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         alone (56 percent) or in combination with
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         (55 percent) or bleach baths (63 percent) than education alone (38 percent) [
         <a href="#rid16">
          16
         </a>
         ]. However, at four months, the only regimen more effective than education alone was mupirocin plus bleach baths (71 versus 48 percent). Recurrent SSTI was common, occurring in 20 percent of participants at one month and 36 percent of participants at four months, suggesting that factors other than endogenous colonization play a role in MRSA infection. In another open-label randomized trial in 987 children with probable community-associated
         <em>
          S. aureus
         </em>
         SSTI or invasive infection, the rates of medically attended recurrence over 12 months were similar in those assigned to hygienic measures alone and hygienic measures combined with bleach baths twice per week for three months (21 and 17 percent, respectively) [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Although close contacts may serve as a reservoir for MRSA transmission [
         <a href="#rid8">
          8,25,26
         </a>
         ], evidence to support decolonization to prevent household transmission is limited [
         <a href="#rid27">
          27,28
         </a>
         ]. In an open-label randomized trial in 183 children with community-onset
         <em>
          S. aureus
         </em>
         skin abscess and colonization, decolonization of all household members was not found to be more effective than isolated decolonization of the index patient in eradicating
         <em>
          S. aureus
         </em>
         colonization [
         <a href="#rid27">
          27
         </a>
         ]. However, over the 12-month follow-up, there was a reduction in self-reported SSTI in the index patient (52 versus 72 percent) and a nonsignificant trend toward fewer reported SSTIs in household contacts (16 versus 22 percent). The five-day decolonization regimen consisted of twice-daily intranasal
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         and once-daily
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         body washes. However, a follow-up randomized trial that compared the same five-day decolonization strategy for the child and members of the household with MRSA infection in the previous year with decolonization for all members of the household found similar frequencies of recurrence in the three months after enrollment (approximately 10 percent) [
         <a href="#rid21">
          21
         </a>
         ]. Additional study is necessary to determine optimal duration of decolonization and/or the effectiveness of environmental decontamination.
        </p>
        <p class="headingAnchor" id="H909975415">
         <span class="h3">
          Children with atopic dermatitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Topical decolonization for children with atopic dermatitis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3637499813">
         <span class="h1">
          DECOLONIZATION REGIMENS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies evaluating the efficacy of decolonization regimens are limited [
         <a href="#rid16">
          16,27,29,30
         </a>
         ] and the optimal regimen for decolonization in specific patient populations is uncertain [
         <a href="#rid31">
          31
         </a>
         ]. Decolonization regimens for neonates in the intensive care unit are discussed below. (See
         <a class="local">
          'Neonatal intensive care unit'
         </a>
         below.)
        </p>
        <p>
         Decolonization regimens suggested by the Infectious Diseases Society of America or that have some evidence of efficacy in clinical trials in infants, children, and adolescents are provided in the bullets below. Intranasal and topical decolonization regimens may be used alone or in combination; topical decolonization regimens may also be used in combination (on different days).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intranasal decolonization for infants, children, and adolescents
         </strong>
         – Regimens for intranasal decolonization include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment applied to the anterior nares twice daily for 5 to 10 days [
         <a href="#rid13">
          13
         </a>
         ],
         <strong>
          or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment applied to the anterior nares twice daily for 5 days twice per month for six months [
         <a href="#rid30">
          30
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A potential complication of
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         therapy is the development of mupirocin resistance, particularly with repeated or long-term use [
         <a href="#rid32">
          32-34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Topical decolonization
         </strong>
         <strong>
          for infants, children, and adolescents
         </strong>
         – Topical decolonization regimens for infants, children, and adolescents include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         (applied with the hands or a clean washcloth and rinsed off) once daily for 5 to 14 days [
         <a href="#rid16">
          16
         </a>
         ],
         <strong>
          or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dilute bleach baths (1 teaspoon of bleach per gallon of water, one-fourth of a cup of bleach per one-fourth of a standard bathtub of water, or one-fourth of a cup of bleach per 13 gallons of water) for 15 minutes twice weekly for approximately three months [
         <a href="#rid13">
          13,16,24
         </a>
         ],
         <strong>
          or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         (applied with the hands or a clean washcloth and rinsed off) once daily for 5 days, twice per month for six months [
         <a href="#rid30">
          30
         </a>
         ],
         <strong>
          or
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dilute bleach baths (1 teaspoon of bleach per gallon of water, one-fourth of a cup of bleach per one-fourth of a standard bathtub of water, or one-fourth of a cup of bleach per 13 gallons of water) for 15 minutes twice weekly. On the days that bleach baths are not given,
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         baths or showers (applied with the hands or a clean washcloth and rinsed off) once daily five times per week for approximately three months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         After bleach baths or
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         baths or showers, patients should generously moisturize the skin; bleach and chlorhexidine both cause drying of the skin. Chlorhexidine may cause local irritation, and repeated exposure may be associated with decreased susceptibility [
         <a href="#rid19">
          19,20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative decolonization
         </strong>
         – May be warranted for children who will be undergoing cardiac surgery or children who are scheduled for an implantable device (eg, cerebrospinal fluid shunt, spinal instrumentation,
         <a class="drug drug_pediatric" data-topicid="12983" href="/z/d/drug information/12983.html" rel="external">
          baclofen
         </a>
         pump) [
         <a href="#rid35">
          35
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment to the anterior nares twice per day for the five days before surgery,
         <strong>
          and
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         bath (as described above) or chlorhexidine antiseptic wipes for the five days before surgery
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The final
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         bath or wipe should be performed on the morning of surgery or after 5 PM on the night before surgery; if performed the night before surgery, a full linen change should be performed immediately after the bath.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3073366748">
         <span class="h1">
          BASELINE STRATEGIES FOR HEALTH CARE SETTINGS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prevention of MRSA in health care settings requires a multifaceted approach [
         <a href="#rid31">
          31,36
         </a>
         ]. Baseline strategies are appropriate for most institutions or units.
        </p>
        <p class="headingAnchor" id="H4044606630">
         <span class="h2">
          Infection control
         </span>
        </p>
        <p class="headingAnchor" id="H494151906">
         <span class="h3">
          Standard precautions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Standard precautions are recommended in the care of all patients in the health care setting. Standard precautions include hand hygiene before and after contact with every patient and wearing gloves if exposure to blood or body fluids is anticipated. Additional details of standard precautions are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4042.html" rel="external">
          "Infection prevention: Precautions for preventing transmission of infection", section on 'Standard precautions'
         </a>
         .)
        </p>
        <p>
         In observational studies, increased adherence to hand hygiene has been associated with reductions in rates of MRSA transmission and prevalence of health care-associated infection [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3260930038">
         <span class="h3">
          Contact precautions
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to standard precautions, contact precautions are recommended for patients infected or known to be colonized with MRSA and patients with draining wounds or abscesses if the wound cannot be covered or the drainage cannot be contained by the dressing [
         <a href="#rid39">
          39-41
         </a>
         ].
        </p>
        <p>
         Contact precautions for patients infected or colonized with MRSA include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Placing the patient in a private room, or placing two or more patients with MRSA in the same room.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wearing clean, nonsterile gloves when entering the patient's room; removing the gloves and performing hand hygiene upon leaving the patient's room.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wearing a gown when entering the room if substantial contact with the patient or environmental surfaces in the room is anticipated or if the patient has wound drainage not contained by a dressing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Removing the gown and gloves and performing hand hygiene before leaving the patient's room.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Limiting transport of the patient from the room to essential purposes only.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When possible, dedicating the use of noncritical equipment (eg, stethoscope) to a single patient or cohort of patients. If use for another patient is unavoidable, the item should be adequately cleaned and disinfected before use.
        </p>
        <p>
        </p>
        <p>
         Additional aspects of contact precautions are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4042.html" rel="external">
          "Infection prevention: Precautions for preventing transmission of infection", section on 'Contact precautions'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3036910353">
         <span class="h3">
          Duration of contact precautions
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with MRSA infection
         </strong>
         – For patients with MRSA infection who are receiving antimicrobial therapy with activity against MRSA, contact precautions should be continued throughout admission [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Patients with MRSA colonization
         </strong>
         – The duration of contact precautions for patients with MRSA colonization who are not receiving antimicrobial therapy with activity against MRSA varies from institution to institution [
         <a href="#rid31">
          31
         </a>
         ]. The decision to discontinue contact precautions for patients with MRSA colonization must balance the benefit of decreased transmission with potential harms, including cost and unintended consequences (eg, fewer interactions between the patient and health care providers) [
         <a href="#rid43">
          43-46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We agree with the Society for Healthcare Epidemiology of America that the decision to discontinue contact precautions for patients outside the neonatal intensive care unit should be guided by screening cultures [
         <a href="#rid42">
          42
         </a>
         ], although the optimal number of negative cultures or interval between cultures has not been established. Surveillance cultures are discussed below. (See
         <a class="local">
          'Screening asymptomatic patients'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Many institutions require one to three negative surveillance cultures obtained at least 24 hours apart [
         <a href="#rid42">
          42,47
         </a>
         ]. In a multicenter study, 94 percent of patients colonized with MRSA were culture negative after three consecutive cultures collected at weekly intervals [
         <a href="#rid48">
          48
         </a>
         ]. Longer duration of contact precautions may be warranted for patients with chronic wounds or from long-term care facilities [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         At the author's institution, all of the following criteria must be met for discontinuation of contact precautions:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         No antimicrobial therapy (topical or systemic) with activity against MRSA for ≥7 days before collection of samples for screening cultures or polymerase chain reaction (PCR).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Negative MRSA culture from the original site of infection, if accessible (eg, wounds, urine if the patient has a urinary catheter, tracheal aspirate if the patient has a tracheostomy or endotracheal tube in place)
         <strong>
          except
         </strong>
         if the original site was the bloodstream or cerebrospinal fluid and the patient is clinically cured.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Negative MRSA PCR surveillance swab (ie, a single swab is used to swab both anterior nares, both axillae, and both inguinal areas [in that order], with each site swabbed for three seconds).
        </p>
        <p>
        </p>
        <p>
         If MRSA PCR is not available, MRSA surveillance cultures may be obtained in a similar manner.
        </p>
        <p class="headingAnchor" id="H1815907182">
         <span class="h2">
          Chlorhexidine bathing for PICU patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         bathing of children in the pediatric intensive care unit (PICU) is routine in many institutions. At the author's institution, daily chlorhexidine bathing is routinely employed for PICU patients with central lines.
        </p>
        <p>
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          Chlorhexidine
         </a>
         is a broad-spectrum antiseptic agent. Daily bathing with chlorhexidine is safe and may be effective in decreasing hospital-acquired infections (eg, bloodstream infections, ventilator-associated pneumonia) and colonization with drug-resistant organisms, including MRSA [
         <a href="#rid50">
          50-54
         </a>
         ]. In per-protocol analysis of a multicenter, cluster-randomized, crossover trial in PICUs, daily chlorhexidine bathing modestly decreased the incidence of bacteremia (3.28 versus 4.93 per 1000 days, adjusted incidence rate ratio 0.64, 95% CI 0.42-0.98) compared with standard bathing practices [
         <a href="#rid54">
          54
         </a>
         ]. In a meta-analysis of eight randomized trials (including the PICU trial), chlorhexidine bathing reduced the rate of hospital-acquired infections from 9.5 to 7.8 infections per 1000 patient days (rate difference 1.70, 95% CI 0.12-3.29) [
         <a href="#rid55">
          55
         </a>
         ]. The quality of evidence was limited by inconsistency and lack of blinding in most of the included studies.
        </p>
        <p class="headingAnchor" id="H4173430739">
         <span class="h2">
          Identifying MRSA in symptomatic patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRSA may be transmitted from infected patients to health care workers or other patients [
         <a href="#rid31">
          31,56-58
         </a>
         ]. Identifying MRSA in symptomatic patients is achieved through laboratory-based detection (eg, clinical cultures). In patients with suspected MRSA infection, microbiologic specimens for culture and other MRSA testing should be obtained from wounds and other relevant sites (eg, blood, joint fluid) as discussed in individual topic reviews. (See
         <a class="medical medical_review" href="/z/d/html/6027.html" rel="external">
          "Skin and soft tissue infections in children &gt;28 days: Evaluation and management", section on 'Laboratory evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6030.html" rel="external">
          "Bacterial arthritis: Clinical features and diagnosis in infants and children", section on 'Laboratory evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6067.html" rel="external">
          "Hematogenous osteomyelitis in children: Evaluation and diagnosis", section on 'Microbiology'
         </a>
         .)
        </p>
        <p>
         Once identified, children with documented MRSA infection should be placed on contact precautions to prevent transmission to health care workers or other patients. Laboratory-based alert systems may facilitate rapid implementation of contact precautions [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="local">
          'Contact precautions'
         </a>
         above.)
        </p>
        <p>
         Patients with documented MRSA infection may remain colonized for months after completion of treatment [
         <a href="#rid22">
          22,49
         </a>
         ]. Tracking such patients permits prompt implementation of contact precautions if they are readmitted [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4205177379">
         <span class="h2">
          Other baseline measures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Discussions of other baseline measures that may be undertaken at the institutional level (eg, environmental cleaning, monitoring adherence to infection control precautions, prevalence surveys of particular patient populations) are beyond the scope of this review. They are discussed in greater detail in guidelines from the Society for Healthcare Epidemiology of America [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H387228123">
         <span class="h1">
          SECOND-TIER STRATEGIES FOR HEALTH CARE SETTINGS
         </span>
        </p>
        <p class="headingAnchor" id="H886606630">
         <span class="h2">
          Individualized implementation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Decisions regarding implementation of second-tier strategies, which second-tier strategies or combination of strategies to use, and in what order should be individualized in consultation with experts in infection control and hospital epidemiology. The approach described here is consistent with that provided by the Society for Healthcare Epidemiology of America [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         Second-tier strategies may be warranted in institutions, units, or populations with unacceptably high rates of MRSA despite implementation of baseline strategies (eg, in a health care outbreak) and in high-risk neonates in the neonatal intensive care unit (NICU) (eg, preterm low birth weight, indwelling devices, preoperative) [
         <a href="#rid31">
          31,59
         </a>
         ]. What is considered "unacceptably high" depends upon an institution's background rate of MRSA and whether it is increasing or decreasing in response to baseline strategies. An outbreak is defined as a higher than expected number of MRSA cases for a given area (eg, hospital unit) or population over a specific period of time [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         Although observational studies provide evidence supporting the effectiveness of various combinations of strategies [
         <a href="#rid50">
          50,61,62
         </a>
         ], there remains much uncertainty about the magnitude of effect and the optimal process for implementation of individual or combined strategies (eg, duration of contact precautions for colonized patients, which anatomic sites to sample to detect colonization, which patients should undergo decolonization, which regimen should be used for decolonization, need for follow-up cultures after decolonization).
        </p>
        <p class="headingAnchor" id="H3084699528">
         <span class="h2">
          Screening asymptomatic patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asymptomatic patients who are colonized with MRSA are an important reservoir for MRSA transmission and infection [
         <a href="#rid63">
          63
         </a>
         ]. Decisions about screening asymptomatic patients (ie, active surveillance) for MRSA in a particular institution or unit are individualized according to the rate of health care-associated MRSA infection [
         <a href="#rid31">
          31
         </a>
         ]. Active surveillance facilitates prompt institution of contact precautions and may permit targeted decolonization, but high-quality evidence of benefits (eg, decreased incidence of MRSA, decreased MRSA infection) and harms (resource utilization) is lacking [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         Although consensus regarding which patients to screen is lacking, active surveillance may be beneficial in the setting of a health care outbreak or in patients at increased risk of MRSA colonization, including patients who:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Are in the intensive care unit (ICU) or NICU [
         <a href="#rid50">
          50,61,65-67
         </a>
         ]; active surveillance in the NICU is discussed below (see
         <a class="local">
          'Neonatal intensive care unit'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Have skin or soft tissue infection
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Have a history of MRSA colonization [
         <a href="#rid68">
          68
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Are immunocompromised
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Were hospitalized in the previous 12 months [
         <a href="#rid69">
          69,70
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Have received antibiotic therapy in the previous three months [
         <a href="#rid70">
          70
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Are residents of long-term care facilities [
         <a href="#rid64">
          64
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         When active surveillance is undertaken, MRSA can be detected with culture or polymerase chain reaction (PCR) [
         <a href="#rid31">
          31,67,71
         </a>
         ]. Outside of the NICU setting, bioluminescence assays are another method for active surveillance [
         <a href="#rid31">
          31,71
         </a>
         ]. Surveillance results are available sooner with PCR assays than cultures, but PCR assays are more expensive. Specimens are usually obtained from the anterior nares, which is the most frequently positive site, although sensitivity may be as low as 48 percent [
         <a href="#rid72">
          72
         </a>
         ]. Sampling of additional sites (eg, inguinal area, perineum, perianal area, throat, umbilicus [in neonates]) increases the yield [
         <a href="#rid67">
          67,73-76
         </a>
         ].
        </p>
        <p>
         Identifying asymptomatic patients colonized with MRSA may help to prevent MRSA transmission and infection in the health care setting because colonized patients may transmit MRSA and because a substantial proportion of patients colonized with MRSA develop MRSA infection [
         <a href="#rid31">
          31,58,77,78
         </a>
         ]. In a retrospective study, 8.5 percent of 153 children who were colonized with MRSA at the time of admission to a pediatric intensive care unit (PICU) subsequently developed MRSA infection, often after discharge; among the 15 children who were newly colonized with MRSA during their ICU stay, 7 developed MRSA infection [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
         Active surveillance has been associated with decreased incidence of MRSA in several observational studies (predominantly in adult patients) [
         <a href="#rid79">
          79-82
         </a>
         ]. However, active surveillance was generally a component of a multifaceted approach, and the individual contribution of active surveillance is uncertain [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4146216917">
         <span class="h2">
          Decolonization
         </span>
        </p>
        <p class="headingAnchor" id="H3920732717">
         <span class="h3">
          Targeted decolonization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Targeted decolonization of patients colonized with MRSA may decrease the risk of infection in the colonized patient and transmission to noncolonized patients [
         <a href="#rid59">
          59,61,62,83
         </a>
         ].
        </p>
        <p>
         Targeted decolonization may be warranted as part of a multifaceted approach in the setting of a health care outbreak and in hospitals or units with an unacceptably high incidence of MRSA. It is also reasonable in the preoperative care of children who will be undergoing cardiac surgery or children who are scheduled for an implantable device (eg, cerebrospinal fluid shunt, spinal instrumentation,
         <a class="drug drug_pediatric" data-topicid="12983" href="/z/d/drug information/12983.html" rel="external">
          baclofen
         </a>
         pump) [
         <a href="#rid35">
          35
         </a>
         ]. However, there remain many unanswered questions (eg, optimal regimen, duration) and consensus is lacking. (See
         <a class="local">
          'Decolonization regimens'
         </a>
         above.)
        </p>
        <p>
         Targeted decolonization in of NICU patients is discussed below. (See
         <a class="local">
          'Neonatal intensive care unit'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3051558911">
         <span class="h3">
          Universal decolonization
         </span>
         <span class="headingEndMark">
          —
         </span>
         Universal decolonization refers to decolonization of all patients in a particular setting (eg, ICU). It can be implemented immediately upon admission because it does not require surveillance testing [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
         Universal decolonization may be warranted for patients hospitalized in the ICU if there is an unacceptably high rate of MRSA or during an outbreak. Studies in adult ICU patients support universal rather than targeted decolonization for prevention of MRSA infection [
         <a href="#rid50">
          50-52
         </a>
         ]. A multicenter, cluster-randomized, crossover trial supports universal
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         bathing for prevention of bacteremia (not limited to MRSA bacteremia) [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="local">
          'Chlorhexidine bathing for PICU patients'
         </a>
         above.)
        </p>
        <p>
         Universal decolonization of NICU patients is discussed below. (See
         <a class="local">
          'Neonatal intensive care unit'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H271443292">
         <span class="h2">
          Special settings or populations
         </span>
        </p>
        <p class="headingAnchor" id="H2789156472">
         <span class="h3">
          Neonatal intensive care unit
         </span>
         <span class="headingEndMark">
          —
         </span>
         MRSA colonization and infection is associated with substantial morbidity in neonates [
         <a href="#rid84">
          84-87
         </a>
         ]. In addition to baseline prevention strategies, active surveillance and targeted or universal decolonization may be warranted in a unit with an unacceptably high incidence of MRSA or to control an outbreak [
         <a href="#rid67">
          67,88
         </a>
         ]. Decisions regarding these strategies are individualized in consultation with experts in infection control and hospital epidemiology. Evidence that these strategies are effective is limited. The potential benefits of decolonization must be balanced against the unknown effects on the neonates' microbiota and potential for infections with other microorganisms [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contact precautions
         </strong>
         – Contact precautions are recommended for patients known to be colonized with MRSA [
         <a href="#rid39">
          39-41
         </a>
         ]. The duration of contact precautions for MRSA-colonized infants in the NICU varies from institution to institution. Given the high rates of persistent or recurrent colonization, particularly in infants with ventilatory devices (eg, endotracheal tubes, nasal prongs) that may be reservoirs of infection [
         <a href="#rid89">
          89-91
         </a>
         ], we continue contact precautions for the duration of hospitalization. This approach is consistent with guidance from the Society for Healthcare Epidemiology of America [
         <a href="#rid88">
          88
         </a>
         ]. An alternative approach uses serial surveillance testing to document clearance of colonization before discontinuation and continued clearance after discontinuation. This approach is described above. (See
         <a class="local">
          'Duration of contact precautions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Active surveillance
         </strong>
         – Active surveillance for MRSA informs decisions about other infection control measures (eg, contact isolation, decolonization) [
         <a href="#rid88">
          88
         </a>
         ]. In nonoutbreak settings, active surveillance of NICU patients without decolonization does not appear to affect the incidence of MRSA. In observational studies, active surveillance combined with isolation and patient cohorting was not associated with consistent decline in the incidence of MRSA [
         <a href="#rid92">
          92,93
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Active surveillance and targeted
         </strong>
         <strong>
          decolonization
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Active surveillance and targeted decolonization of neonates
         </strong>
         – Active surveillance and targeted decolonization successfully eradicates
         <em>
          S. aureus
         </em>
         carriage in the short-term, but recolonization is common [
         <a href="#rid94">
          94-97
         </a>
         ]. In a multicenter trial, 155 NICU infants &lt;24 months of age who were colonized with
         <em>
          S. aureus
         </em>
         were randomly assigned to five days of treatment with topical
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         every eight hours (intranasal, periumbilical, and perianal) or no treatment [
         <a href="#rid94">
          94
         </a>
         ]. Mupirocin resulted in primary decolonization on day 8 (94 versus 5 percent), but more than 50 percent of treated infants were recolonized by day 22 and 70 percent by day 85.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Targeted decolonization also may reduce the risk of subsequent MRSA infection in colonized neonates [
         <a href="#rid62">
          62,89,94-96,98-100
         </a>
         ]. In an experimental study, decolonization (
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         ointment applied to the nares and umbilicus twice daily for five days) of colonized neonates was associated with decreased rate of clinical MRSA infection (3 versus 16 percent) [
         <a href="#rid95">
          95
         </a>
         ]. In the multicenter trial described in the previous paragraph, fewer decolonized neonates developed clinically significant
         <em>
          S. aureus
         </em>
         infections, but the result was not statistically significant [
         <a href="#rid94">
          94
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Active surveillance and targeted decolonization of parents
         </strong>
         – Active surveillance and targeted decolonization of parents or caregivers of NICU infants may be helpful in preventing transmission. Parents are a primary reservoir for
         <em>
          S. aureus
         </em>
         infections in infants [
         <a href="#rid101">
          101-103
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In a randomized trial in two NICUs with a comprehensive
         <em>
          S. aureus
         </em>
         surveillance and decolonization program,
         <em>
          S. aureus
         </em>
         -colonized parents of 208 NICU infants with no history of positive
         <em>
          S. aureus
         </em>
         cultures were assigned to a five-day decolonization regimen (intranasal
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         and
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         bathing) or placebo (intranasal petrolatum and bathing with nonmedicated soap) [
         <a href="#rid101">
          101
         </a>
         ]. Among the 190 infants available for follow-up at 90 days, 74 neonates (39 percent) were colonized with
         <em>
          S. aureus
         </em>
         ;
         <em>
         </em>
         57 percent of colonized neonates had the same strain as their parents. The proportion of concordant
         <em>
          S. aureus
         </em>
         acquisition was similar for MRSA (8 percent of isolates) and methicillin-susceptible
         <em>
          S. aureus
         </em>
         (92 percent of isolates). Fewer infants whose parents were assigned to decolonization acquired
         <em>
          S. aureus
         </em>
         colonization with a concordant strain (14.6 versus 28.7 percent; risk difference -14.1 percent, 95% CI -30.8 to -3.9) or with any strain of
         <em>
          S. aureus
         </em>
         (31.4 versus 45.5 percent). The study sample was too small to detect differences in rates of
         <em>
          S. aureus
         </em>
         infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Additional studies are necessary to confirm these findings to determine if they are generalizable to other settings (eg, NICUs without preexisting surveillance and decolonization programs) before routine adoption of this strategy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Universal decolonization
         </strong>
         – Universal decolonization of NICU patients may be warranted if other strategies have failed. Evidence of efficacy and safety are limited [
         <a href="#rid59">
          59,67,104
         </a>
         ]. In quasi-experimental studies, universal decolonization of NICU infants with
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         was associated with outbreak control and decreased prevalence of MRSA [
         <a href="#rid105">
          105-107
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Decolonization regimen
         </strong>
         – The optimal decolonization regimen for preterm infants is uncertain [
         <a href="#rid67">
          67,88
         </a>
         ]. Most studies have used
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         ointment rather than
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         for topical decolonization. Topical chlorhexidine may cause skin irritation and burns and may be systemically absorbed in neonates [
         <a href="#rid108">
          108-111
         </a>
         ]. Topical decolonization regimens for neonates include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment applied to the intranasal, periumbilical, and perianal regions twice per day for five days [
         <a href="#rid94">
          94,95
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment applied to the intranasal and periumbilical regions, eroded skin, and wounds twice daily throughout hospitalization [
         <a href="#rid106">
          106
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          Mupirocin
         </a>
         ointment applied to the intranasal region three times daily for three days, and then three times per week [
         <a href="#rid105">
          105
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Topical
         <a class="drug drug_pediatric" data-topicid="12622" href="/z/d/drug information/12622.html" rel="external">
          mupirocin
         </a>
         in preterm infants is generally well tolerated. In an open-label randomized trial, rash was more common in mupirocin recipients than in controls (22 versus 5 percent) [
         <a href="#rid94">
          94
         </a>
         ]. Development of mupirocin resistance is a concern [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2466760830">
         <span class="h3">
          Health care outbreak
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of a health care outbreak of MRSA requires a multifaceted approach. Individual components (which may be bundled in various combinations) include [
         <a href="#rid61">
          61,113-116
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Strict adherence to infection control measures (standard and contact precautions) and environmental cleaning (see
         <a class="local">
          'Baseline strategies for health care settings'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         During a NICU outbreak, soaps containing
         <a class="drug drug_pediatric" data-topicid="13146" href="/z/d/drug information/13146.html" rel="external">
          chlorhexidine
         </a>
         or alcohol-based hand rubs are preferred to plain soap and water for hand hygiene [
         <a href="#rid117">
          117-119
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cohorting patients and nurses
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Active surveillance and decolonization of patients (see
         <a class="local">
          'Screening asymptomatic patients'
         </a>
         above and
         <a class="local">
          'Decolonization'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Active surveillance and nasal decolonization of health care workers on the involved unit(s) may be warranted if transmission continues despite appropriate identification and isolation of MRSA cases, particularly if a single strain is responsible
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Universal decolonization [
         <a href="#rid105">
          105,120,121
         </a>
         ] (see
         <a class="local">
          'Universal decolonization'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Molecular analysis to identify sources of MRSA [
         <a href="#rid122">
          122,123
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1241295264">
         <span class="h1">
          VACCINATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Efforts to develop a
         <em>
          S. aureus
         </em>
         vaccine are ongoing [
         <a href="#rid124">
          124-126
         </a>
         ]. Some candidate vaccines demonstrate promise, but none is licensed.
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          PREVENTION OF VISA AND VRSA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vancomycin-intermediate
         <em>
          S. aureus
         </em>
         (VISA) is defined as a
         <a class="drug drug_pediatric" data-topicid="12874" href="/z/d/drug information/12874.html" rel="external">
          vancomycin
         </a>
         minimum inhibitory concentration (MIC) 4 through 8 mcg/mL [
         <a href="#rid127">
          127,128
         </a>
         ]. Vancomycin-resistant
         <em>
          S. aureus
         </em>
         (VRSA) is defined as a vancomycin MIC ≥16 mcg/mL [
         <a href="#rid127">
          127,128
         </a>
         ]. VISA and VRSA isolates have been rarely reported in children [
         <a href="#rid129">
          129
         </a>
         ].
        </p>
        <p>
         We follow the Centers for Disease Control and Prevention's (CDC)
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fhai%2Forganisms%2Fvisa_vrsa%2Fvisa_vrsa.html&amp;token=R4Uiw8%2FbmPVaqNHRDqpXLJ%2BDwLrnoTpi3IoA0aEfdFUVoS1gz0aowm0TvBUecL0ZEm3u16OOdp1oXkOOgM0IPg%3D%3D&amp;TOPIC_ID=6025" target="_blank">
          recommendations for prevention of VISA and VRSA infections
         </a>
         , including [
         <a href="#rid130">
          130
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Isolate the patient in a private room
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Minimize the number of personnel caring for the patient (eg, assign dedicated caregivers)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Implement appropriate infection control precautions (standard and contact precautions); dedicate nondisposable items that cannot be cleaned and disinfected between patients (eg, adhesive tape, cloth-covered blood pressure cuffs) for use only on the patient
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inform appropriate health care personnel that the patient has VISA/VRSA to ensure they understand the need for contact precautions
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flag the patient's electronic medical record/chart to indicate infection/colonization with VISA/VRSA
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consult with the local and/or state health department and CDC before transferring or discharging the patient
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ensure that the patient's VISA/VRSA status and required infection control precautions are communicated at transfer
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3801321082">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110550.html" rel="external">
          "Society guideline links: Management of
          <i>
           Staphylococcus aureus
          </i>
          infection"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/4025.html" rel="external">
          "Patient education: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2175219919">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention in the community
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Education
         </strong>
         – Education of patients and family members about hygiene and cleaning of surfaces and other items that are frequently touched with bare skin (eg, door knobs, bath tubs, counters, television remote controls, athletic equipment) is a key component of prevention of methicillin-resistant
         <em>
          Staphylococcus aureus
         </em>
         (MRSA) in the community. (See
         <a class="local">
          'Education to reduce transmission'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Isolation from school or child care is not routinely necessary
         </strong>
         – Children with MRSA infection may attend school or child care provided that draining or open wounds or abrasions can be kept covered with a clean, dry dressing. Those who are colonized with MRSA should not routinely be excluded from school or child care. (See
         <a class="local">
          'School or child care attendance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Indications for decolonization
         </strong>
         – For children with recurrent MRSA infection despite routine hygiene measures, we suggest intranasal and topical decontamination (
         <a class="graphic graphic_table graphicRef121267" href="/z/d/graphic/121267.html" rel="external">
          table 1
         </a>
         ) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For children with multiple recurrences of MRSA despite routine hygiene measures who have ≥1 other household member with MRSA infections, we suggest intranasal and topical decolonization for all household members with
         <em>
          S. aureus
         </em>
         infections in the previous year in addition to intranasal and topical decolonization of the child (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Decolonization is well tolerated and may reduce the risk of subsequent MRSA infection in the patient and their contacts. (See
         <a class="local">
          'Children with recurrent MRSA infection'
         </a>
         above and
         <a class="local">
          'Decolonization regimens'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevention in health care settings
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Baseline strategies
         </strong>
         – Prevention and control of MRSA in health care settings requires a multifaceted approach. Baseline strategies include standard precautions, contact precautions for patients infected or known to be colonized with MRSA, and identification of MRSA in symptomatic patients. (See
         <a class="local">
          'Baseline strategies for health care settings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Second tier strategies
         </strong>
         – Implementation of second-tier strategies is individualized in consultation with experts in infection control and hospital epidemiology. Second-tier strategies may be warranted in institutions, units, or populations with unacceptably high rates of MRSA despite implementation of baseline strategies. (See
         <a class="local">
          'Individualized implementation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Second-tier strategies include screening asymptomatic patients and targeted or universal decolonization. These strategies often are used in combination with baseline strategies or other second-tier strategies. Multifaceted approaches have been successful in reducing the incidence of MRSA and controlling outbreaks, but the optimal approach is uncertain. (See
         <a class="local">
          'Screening asymptomatic patients'
         </a>
         above and
         <a class="local">
          'Decolonization'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Prevention in the NICU
         </strong>
         – In the neonatal intensive care unit (NICU), active surveillance and targeted decolonization successfully eradicates
         <em>
          S. aureus
         </em>
         in the short term, and may reduce the risk of subsequent MRSA infection, but recolonization is common. Universal decolonization may be warranted if other strategies fail, but evidence of efficacy and safety are limited. The potential benefits of decolonization must be balanced against the unknown effects on the neonates' microbiota and potential for infections with other microorganisms. (See
         <a class="local">
          'Neonatal intensive care unit'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62:e51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kanwar A, Cadnum JL, Jencson AL, Donskey CJ. Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus among Hospitalized Patients. Antimicrob Agents Chemother 2018; 62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blumenthal KG, Lu N, Zhang Y, et al. Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ 2018; 361:k2400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sacco KA, Bates A, Brigham TJ, et al. Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis. Allergy 2017; 72:1288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adcock PM, Pastor P, Medley F, et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998; 178:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mork RL, Hogan PG, Muenks CE, et al. Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study. Lancet Infect Dis 2020; 20:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hogan PG, Mork RL, Thompson RM, et al. Environmental Methicillin-resistant Staphylococcus aureus Contamination, Persistent Colonization, and Subsequent Skin and Soft Tissue Infection. JAMA Pediatr 2020; 174:552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fritz SA, Hogan PG, Singh LN, et al. Contamination of environmental surfaces with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus. JAMA Pediatr 2014; 168:1030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elias AF, Chaussee MS, McDowell EJ, Huntington MK. Community-based intervention to manage an outbreak of MRSA skin infections in a county jail. J Correct Health Care 2010; 16:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 2004; 39:1446.
          </a>
         </li>
         <li class="breakAll">
          Gorwitz, RJ, Jernigan, DB, Powers, JH, et al. Strategies for clinical management of MRSA in the community: Summary of an experts' meeting convened by the Centers for Disease Control and Prevention. 2006. www.cdc.gov/mrsa/pdf/MRSA-Strategies-ExpMtgSummary-2006.pdf (Accessed on December 13, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davies HD, Jackson MA, Rice SG, et al. Infectious Diseases Associated With Organized Sports and Outbreak Control. Pediatrics 2017; 140.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Staphylococcus aureus. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.678.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fritz SA, Camins BC, Eisenstein KA, et al. Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial. Infect Control Hosp Epidemiol 2011; 32:872.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA). Laundry. Available at: https://www.cdc.gov/mrsa/community/environment/laundry.html (Accessed on April 20, 2019).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA). For School and Daycare. Available at: https://www.cdc.gov/mrsa/community/schools/index.html (Accessed on April 06, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kampf G. Acquired resistance to chlorhexidine - is it time to establish an 'antiseptic stewardship' initiative? J Hosp Infect 2016; 94:213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mimoz O, Lucet JC, Kerforne T, et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 2015; 386:2069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hogan PG, Parrish KL, Mork RL, et al. HOME2 Study: Household Versus Personalized Decolonization in Households of Children With Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infection-A Randomized Clinical Trial. Clin Infect Dis 2021; 73:e4568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cluzet VC, Gerber JS, Nachamkin I, et al. Factors associated with persistent colonisation with methicillin-resistant Staphylococcus aureus. Epidemiol Infect 2017; 145:1409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pittet LF, Curtis N. Are decontamination measures effective in preventing recurrent staphylococcal skin infection in children? Arch Dis Child 2020; 105:603.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan SL, Forbes A, Hammerman WA, et al. Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis 2014; 58:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller LG. Where we are with community-associated Staphylococcus aureus prevention--and in the meantime, what do we tell our patients? Clin Infect Dis 2012; 54:752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zafar U, Johnson LB, Hanna M, et al. Prevalence of nasal colonization among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts. Infect Control Hosp Epidemiol 2007; 28:966.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fritz SA, Hogan PG, Hayek G, et al. Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis 2012; 54:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cluzet VC, Gerber JS, Metlay JP, et al. The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2016; 37:1226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loeb MB, Main C, Eady A, Walker-Dilks C. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003; :CD003340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang SS, Singh R, McKinnell JA, et al. Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers. N Engl J Med 2019; 380:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calfee DP, Salgado CD, Milstone AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irish D, Eltringham I, Teall A, et al. Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. J Hosp Infect 1998; 39:19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vasquez JE, Walker ES, Franzus BW, et al. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 2000; 21:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McNeil JC, Hulten KG, Kaplan SL, Mason EO. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother 2011; 55:2431.
          </a>
         </li>
         <li class="breakAll">
          Foster CE, Ruderfer D, Lamb GS, et al. Staphylococcus aureus screening and decolonization for pediatric patients undergoing surgery at Texas Children's Hospital: A trainee quality improvement initiative. Abstract, ID Week, San Francisco, CA, October 2018. Available at: https://idsa.confex.com/idsa/2018/webprogram/Paper70319.html (Accessed on May 01, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fätkenheuer G, Hirschel B, Harbarth S. Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. Lancet 2015; 385:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356:1307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sroka S, Gastmeier P, Meyer E. Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature. J Hosp Infect 2010; 74:204.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegel JD, Rhinehart E, Jackson M, et al. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007; 35:S165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003; 24:362.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Guideline for isolation precautions: Preventing transmission of infectious agents in healthcare settings (2007). Available at: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html (Accessed on April 04, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banach DB, Bearman G, Barnden M, et al. Duration of Contact Precautions for Acute-Care Settings. Infect Control Hosp Epidemiol 2018; 39:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pegues DA. Editorial commentary: search, destroy, and confirm: how to maximize the benefit and reduce the unintended consequences of contact precautions for control of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2013; 57:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003; 290:1899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morgan DJ, Pineles L, Shardell M, et al. The effect of contact precautions on healthcare worker activity in acute care hospitals. Infect Control Hosp Epidemiol 2013; 34:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saint S, Higgins LA, Nallamothu BK, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003; 31:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shenoy ES, Kim J, Rosenberg ES, et al. Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction. Clin Infect Dis 2013; 57:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huckabee CM, Huskins WC, Murray PR. Predicting clearance of colonization with vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures. J Clin Microbiol 2009; 47:1229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scanvic A, Denic L, Gaillon S, et al. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32:1393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368:2255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013; 368:533.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Derde LP, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect Dis 2014; 14:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Horo JC, Silva GL, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012; 33:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013; 381:1099.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis SR, Schofield-Robinson OJ, Rhodes S, Smith AF. Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection. Cochrane Database Syst Rev 2019; 8:CD012248.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris AD, Furuno JP, Roghmann MC, et al. Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy. Antimicrob Agents Chemother 2010; 54:3143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson RE, Stevens VW, Jones M, et al. Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality. Am J Infect Control 2015; 43:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008; 47:176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popoola VO, Milstone AM. Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit. J Perinatol 2014; 34:805.
          </a>
         </li>
         <li class="breakAll">
          Dicker RC, Coronada F, Koo D, Parrish RG. Lesson 6: Investigating an outbreak. In: Principles of Epidemiology in Public Health Practice, 3rd Edition, 3rd ed, Centers for Disease Control and Prevention, 2006. p.2-1.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khoury J, Jones M, Grim A, et al. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005; 26:616.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pierce R, Lessler J, Popoola VO, Milstone AM. Meticillin-resistant Staphylococcus aureus (MRSA) acquisition risk in an endemic neonatal intensive care unit with an active surveillance culture and decolonization programme. J Hosp Infect 2017; 95:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milstone AM, Song X, Beers C, et al. Unrecognized burden of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus carriage in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2008; 29:1174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glick SB, Samson DJ, Huang ES, et al. Screening for methicillin-resistant Staphylococcus aureus: a comparative effectiveness review. Am J Infect Control 2014; 42:148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43:971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucet JC, Chevret S, Durand-Zaleski I, et al. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003; 163:181.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases Division of Healthcare Quality Promotion. Recommendations for prevention and control of infections in neonatal intensive care unit patients: Staphylococcus aureus. September 2020. https://www.cdc.gov/infectioncontrol/guidelines/NICU-saureus (Accessed on September 22, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harbarth S, Martin Y, Rohner P, et al. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000; 46:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furuno JP, McGregor JC, Harris AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006; 166:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159.
          </a>
         </li>
         <li class="breakAll">
          FDA authorizes marketing of diagnostic test that uses novel technology to detect MRSA bacteria. https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-diagnostic-test-uses-novel-technology-detect-mrsa-bacteria (Accessed on January 04, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Senn L, Basset P, Nahimana I, et al. Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test? Clin Microbiol Infect 2012; 18:E31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lautenbach E, Nachamkin I, Hu B, et al. Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol 2009; 30:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKinnell JA, Huang SS, Eells SJ, et al. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol 2013; 34:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matheson A, Christie P, Stari T, et al. Nasal swab screening for methicillin-resistant Staphylococcus aureus--how well does it perform? A cross-sectional study. Infect Control Hosp Epidemiol 2012; 33:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wisgrill L, Zizka J, Unterasinger L, et al. Active Surveillance Cultures and Targeted Decolonization Are Associated with Reduced Methicillin-Susceptible Staphylococcus aureus Infections in VLBW Infants. Neonatology 2017; 112:267.
          </a>
         </li>
         <li class="breakAll">
          Siegel JD, et al. Management of multidrug resistant organisms in healthcare settings 2006. Healthcare Infection Control Practices Advisory Committee. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf (Accessed on April 14, 2008).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milstone AM, Goldner BW, Ross T, et al. Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission. Clin Infect Dis 2011; 53:853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones M, Jernigan JA, Evans ME, et al. Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers - United States, 2005-2017. MMWR Morb Mortal Wkly Rep 2019; 68:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotilainen P, Routamaa M, Peltonen R, et al. Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland. Emerg Infect Dis 2003; 9:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Trijp MJ, Melles DC, Hendriks WD, et al. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol 2007; 28:970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008; 148:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saiman L, Cronquist A, Wu F, et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003; 24:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson MU, Gallagher PG. Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit. Semin Perinatol 2012; 36:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lake JG, Weiner LM, Milstone AM, et al. Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014. Infect Control Hosp Epidemiol 2018; 39:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ericson JE, Popoola VO, Smith PB, et al. Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants. JAMA Pediatr 2015; 169:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carey AJ, Duchon J, Della-Latta P, Saiman L. The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007. J Perinatol 2010; 30:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akinboyo IC, Zangwill KM, Berg WM, et al. SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Staphylococcus aureus disease prevention. Infect Control Hosp Epidemiol 2020; 41:1251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popoola VO, Budd A, Wittig SM, et al. Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol 2014; 35:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zervou FN, Zacharioudakis IM, Ziakas PD, Mylonakis E. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics 2014; 133:e1015.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popoola VO, Tamma P, Reich NG, et al. Risk factors for persistent methicillin-resistant Staphylococcus aureus colonization in children with multiple intensive care unit admissions. Infect Control Hosp Epidemiol 2013; 34:748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gregory ML, Eichenwald EC, Puopolo KM. Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit. Pediatrics 2009; 123:e790.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geraci DM, Giuffrè M, Bonura C, et al. Methicillin-resistant Staphylococcus aureus colonization: a three-year prospective study in a neonatal intensive care unit in Italy. PLoS One 2014; 9:e87760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotloff KL, Shirley DT, Creech CB, et al. Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units. Pediatrics 2019; 143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang YC, Lien RI, Lin TY. Effect of mupirocin decolonization on subsequent methicillin-resistant Staphylococcus aureus infection in infants in neonatal intensive care units. Pediatr Infect Dis J 2015; 34:241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang YC, Lien RI, Su LH, et al. Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units--a 7-year campaign. PLoS One 2011; 6:e23001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson MU, Shaw J, Gross SJ. Randomized Placebo-Controlled Trial of Topical Mupirocin to Reduce Staphylococcus aureus Colonization in Infants in the Neonatal Intensive Care Unit. J Pediatr 2021; 236:70.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popoola VO, Colantuoni E, Suwantarat N, et al. Active Surveillance Cultures and Decolonization to Reduce Staphylococcus aureus Infections in the Neonatal Intensive Care Unit. Infect Control Hosp Epidemiol 2016; 37:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milstone AM, Budd A, Shepard JW, et al. Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010; 31:558.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuetz CR, Hogan PG, Reich PJ, et al. Factors associated with progression to infection in methicillin-resistant Staphylococcus aureus-colonized, critically ill neonates. J Perinatol 2021; 41:1285.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Milstone AM, Voskertchian A, Koontz DW, et al. Effect of Treating Parents Colonized With Staphylococcus aureus on Transmission to Neonates in the Intensive Care Unit: A Randomized Clinical Trial. JAMA 2020; 323:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jimenez-Truque N, Tedeschi S, Saye EJ, et al. Relationship between maternal and neonatal Staphylococcus aureus colonization. Pediatrics 2012; 129:e1252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geva A, Wright SB, Baldini LM, et al. Spread of methicillin-resistant Staphylococcus aureus in a large tertiary NICU: network analysis. Pediatrics 2011; 128:e1173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson MU, Bizzarro MJ, Dembry LM, et al. One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. J Perinatol 2014; 34:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hitomi S, Kubota M, Mori N, et al. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000; 46:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delaney HM, Wang E, Melish M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013; 33:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ristagno EH, Bryant KA, Boland LF, et al. Effect of Intranasal Mupirocin Prophylaxis on Methicillin-Resistant Staphylococcus aureus Transmission and Invasive Staphylococcal Infections in a Neonatal Intensive Care Unit. Infect Control Hosp Epidemiol 2018; 39:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapman AK, Aucott SW, Milstone AM. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Perinatol 2012; 32:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamma PD, Aucott SW, Milstone AM. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 2010; 31:846.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mullany LC, Darmstadt GL, Tielsch JM. Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries. Pediatr Infect Dis J 2006; 25:665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neri I, Ravaioli GM, Faldella G, et al. Chlorhexidine-Induced Chemical Burns in Very Low Birth Weight Infants. J Pediatr 2017; 191:262.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang HM, Park KC, Park J, et al. Mupirocin and Chlorhexidine Genotypic Resistance Found in Staphylococcus aureus Isolated From Young Infants Below 90 Days Old: A Genetic Basis for Eradication Failure. Pediatr Infect Dis J 2021; 40:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006; 27:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iacobelli S, Colomb B, Bonsante F, et al. Successful control of a Methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit: a retrospective, before-after study. BMC Infect Dis 2013; 13:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheithauer S, Trepels-Kottek S, Häfner H, et al. Healthcare worker-related MRSA cluster in a German neonatology level III ICU: a true European story. Int J Hyg Environ Health 2014; 217:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Recomm Rep 2002; 51:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webster J, Faoagali JL, Cartwright D. Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan. J Paediatr Child Health 1994; 30:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zafar AB, Butler RC, Reese DJ, et al. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 1995; 23:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Song X, Cheung S, Klontz K, et al. A stepwise approach to control an outbreak and ongoing transmission of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Am J Infect Control 2010; 38:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepelletier D, Corvec S, Caillon J, et al. Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success? Am J Infect Control 2009; 37:195.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Köser CU, Holden MT, Ellington MJ, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012; 366:2267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madigan T, Cunningham SA, Patel R, et al. Whole-genome sequencing for methicillin-resistant Staphylococcus aureus (MRSA) outbreak investigation in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2018; 39:1412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giersing BK, Dastgheyb SS, Modjarrad K, Moorthy V. Status of vaccine research and development of vaccines for Staphylococcus aureus. Vaccine 2016; 34:2962.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xu X, Zhu H, Lv H. Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: A meta-analysis of randomized controlled trials. Hum Vaccin Immunother 2018; 14:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Creech CB, Frenck RW Jr, Sheldon EA, et al. Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial. Vaccine 2017; 35:385.
          </a>
         </li>
         <li class="breakAll">
          Clinical and Laboratory Standards Institute (CLSI)/National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. NCCLS document M100-S16. National Committee for Clinical Laboratory Standards, Wayne, PA 2006.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tenover FC, Moellering RC Jr. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis 2007; 44:1208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mason EO, Lamberth LB, Hammerman WA, et al. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol 2009; 47:1628.
          </a>
         </li>
         <li class="breakAll">
          Walters M, Lonsway D, Rasheed K, et al. Investigation and control of vancomycin-resistant Staphylococcus aureus: A guide for health departments and infection control personnel. Atlanta, GA 2015. Available at: http://www.cdc.gov/hai/pdfs/VRSA-Investigation-Guide-05_12_2015.pdf (Accessed on April 20, 2019).
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 6025 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17986491" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27080992" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30012763" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus among Hospitalized Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29950489" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28370003" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Clinical outcomes following inpatient penicillin allergy testing: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9697748" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Methicillin-resistant Staphylococcus aureus in two child care centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31784369" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32227144" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Environmental Methicillin-resistant Staphylococcus aureus Contamination, Persistent Colonization, and Subsequent Skin and Soft Tissue Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25200331" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Contamination of environmental surfaces with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20466702" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Community-based intervention to manage an outbreak of MRSA skin infections in a county jail.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15546080" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15546080" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21208910" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28947608" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Infectious Diseases Associated With Organized Sports and Outbreak Control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28947608" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Infectious Diseases Associated With Organized Sports and Outbreak Control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21828967" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21828967" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21828967" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27671220" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Acquired resistance to chlorhexidine - is it time to establish an 'antiseptic stewardship' initiative?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26388532" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32521007" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : HOME2 Study: Household Versus Personalized Decolonization in Households of Children With Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infection-A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28219463" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Factors associated with persistent colonisation with methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32424036" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Are decontamination measures effective in preventing recurrent staphylococcal skin infection in children?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24265356" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22198785" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Where we are with community-associated Staphylococcus aureus prevention--and in the meantime, what do we tell our patients?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17620245" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prevalence of nasal colonization among patients with community-associated methicillin-resistant Staphylococcus aureus infection and their household contacts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22198793" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27465112" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The Effect of Total Household Decolonization on Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14583969" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30763195" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37381690" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9617681" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10926396" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21282426" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21282426" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25150745" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11073019" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20061061" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Impact of alcohol hand-rub use on meticillin-resistant Staphylococcus aureus: an analysis of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18068814" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Management of multidrug-resistant organisms in health care settings, 2006.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12785411" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12785411" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29321078" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Duration of Contact Precautions for Acute-Care Settings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23572485" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Editorial commentary: search, destroy, and confirm: how to maximize the benefit and reduce the unintended consequences of contact precautions for control of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14532319" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Safety of patients isolated for infection control.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23221195" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The effect of contact precautions on healthcare worker activity in acute care hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14608302" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Do physicians examine patients in contact isolation less frequently? A brief report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23572482" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19244462" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Predicting clearance of colonization with vancomycin-resistant Enterococci and methicillin-resistant Staphylococcus aureus by use of weekly surveillance cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11317238" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23718152" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Targeted versus universal decolonization to prevent ICU infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23388005" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Effect of daily chlorhexidine bathing on hospital-acquired infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24161233" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22314063" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23363666" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31476022" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Chlorhexidine bathing of the critically ill for the prevention of hospital-acquired infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20479207" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25564122" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18532892" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25010222" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25010222" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16092741" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27887754" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Meticillin-resistant Staphylococcus aureus (MRSA) acquisition risk in an endemic neonatal intensive care unit with an active surveillance culture and decolonization programme.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18983253" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Unrecognized burden of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus carriage in the pediatric intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24360519" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Screening for methicillin-resistant Staphylococcus aureus: a comparative effectiveness review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16983607" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12546608" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12546608" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11023722" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16534047" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Identifying groups at high risk for carriage of antibiotic-resistant bacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15983910" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15983910" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22192160" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Which anatomical sites should be sampled for screening of methicillin-resistant Staphylococcus aureus carriage by culture or by rapid PCR test?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19239378" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23295562" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22759548" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Nasal swab screening for methicillin-resistant Staphylococcus aureus--how well does it perform? A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28704818" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Active Surveillance Cultures and Targeted Decolonization Are Associated with Reduced Methicillin-Susceptible Staphylococcus aureus Infections in VLBW Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28704818" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Active Surveillance Cultures and Targeted Decolonization Are Associated with Reduced Methicillin-Susceptible Staphylococcus aureus Infections in VLBW Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21878424" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Methicillin-resistant Staphylococcus aureus colonization and risk of subsequent infection in critically ill children: importance of preventing nosocomial methicillin-resistant Staphylococcus aureus transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30845116" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers - United States, 2005-2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12603986" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Elimination of epidemic methicillin-resistant Staphylococcus aureus from a university hospital and district institutions, Finland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17620246" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18347349" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12785403" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23177801" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29249216" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26502073" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19710681" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32921340" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : SHEA neonatal intensive care unit (NICU) white paper series: Practical approaches to Staphylococcus aureus disease prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24602947" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24616358" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23739081" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Risk factors for persistent methicillin-resistant Staphylococcus aureus colonization in children with multiple intensive care unit admissions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19403471" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Seven-year experience with a surveillance program to reduce methicillin-resistant Staphylococcus aureus colonization in a neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24505312" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Methicillin-resistant Staphylococcus aureus colonization: a three-year prospective study in a neonatal intensive care unit in Italy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30587533" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25742074" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Effect of mupirocin decolonization on subsequent methicillin-resistant Staphylococcus aureus infection in infants in neonatal intensive care units.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21857979" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units--a 7-year campaign.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34023342" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Randomized Placebo-Controlled Trial of Topical Mupirocin to Reduce Staphylococcus aureus Colonization in Infants in the Neonatal Intensive Care Unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26725699" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Active Surveillance Cultures and Decolonization to Reduce Staphylococcus aureus Infections in the Neonatal Intensive Care Unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20334509" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33649431" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Factors associated with progression to infection in methicillin-resistant Staphylococcus aureus-colonized, critically ill neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31886828" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Effect of Treating Parents Colonized With Staphylococcus aureus on Transmission to Neonates in the Intensive Care Unit: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22473373" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Relationship between maternal and neonatal Staphylococcus aureus colonization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22007011" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Spread of methicillin-resistant Staphylococcus aureus in a large tertiary NICU: network analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25010223" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11049705" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22918547" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29606181" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Effect of Intranasal Mupirocin Prophylaxis on Methicillin-Resistant Staphylococcus aureus Transmission and Invasive Staphylococcal Infections in a Neonatal Intensive Care Unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22031047" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20586654" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Chlorhexidine use in the neonatal intensive care unit: results from a national survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16874163" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Safety and impact of chlorhexidine antisepsis interventions for improving neonatal health in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29173315" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Chlorhexidine-Induced Chemical Burns in Very Low Birth Weight Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32925545" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Mupirocin and Chlorhexidine Genotypic Resistance Found in Staphylococcus aureus Isolated From Young Infants Below 90 Days Old: A Genetic Basis for Eradication Failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8452155" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16465630" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24053628" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Successful control of a Methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit: a retrospective, before-after study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23953255" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Healthcare worker-related MRSA cluster in a German neonatology level III ICU: a true European story.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12418624" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8148192" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Elimination of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit after hand washing with triclosan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7677266" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20570396" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : A stepwise approach to control an outbreak and ongoing transmission of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19181423" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Eradication of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit: which measures for which success?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22693998" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30282566" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Whole-genome sequencing for methicillin-resistant Staphylococcus aureus (MRSA) outbreak investigation in a neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27105559" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Status of vaccine research and development of vaccines for Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29064736" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: A meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27866765" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27866765" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17407040" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19403769" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
